scholarly article | Q13442814 |
P50 | author | Susan M Egan | Q38318359 |
Veerendra Koppolu | Q59146862 | ||
P2093 | author name string | P Scott Hefty | |
Jeff M Skredenske | |||
Jiaqin Li | |||
Ichie Osaka | |||
Bria Kettle | |||
P2860 | cites work | Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri | Q24533240 |
Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology | Q24534908 | ||
Allostery in the LacI/GalR family: variations on a theme | Q24653579 | ||
Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility | Q24683572 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis | Q27679180 | ||
Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton | Q28199735 | ||
IpaB mediates macrophage apoptosis induced by Shigella flexneri | Q28254424 | ||
The AraC family transcriptional regulator Rv1931c plays a role in the virulence of Mycobacterium tuberculosis | Q28486737 | ||
A bacterial invasin induces macrophage apoptosis by binding directly to ICE | Q28512900 | ||
Arac/XylS family of transcriptional regulators | Q28776772 | ||
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability | Q29547634 | ||
Thermofluor-based high-throughput stability optimization of proteins for structural studies | Q29614747 | ||
High-density miniaturized thermal shift assays as a general strategy for drug discovery | Q29618133 | ||
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates | Q31037921 | ||
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery | Q33205643 | ||
Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses | Q33279723 | ||
High-throughput screening of the virulence regulator VirF: a novel antibacterial target for shigellosis | Q33541815 | ||
The AraC/XylS family activator RhaS negatively autoregulates rhaSR expression by preventing cyclic AMP receptor protein activation | Q33558066 | ||
Characterization of the Shigella flexneri ipgD and ipgF genes, which are located in the proximal part of the mxi locus | Q33594863 | ||
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes | Q33878820 | ||
Amino acid-DNA contacts by RhaS: an AraC family transcription activator | Q33992786 | ||
Antibiotic overuse: Stop the killing of beneficial bacteria | Q34210630 | ||
Phylogeny of the bacterial superfamily of Crp-Fnr transcription regulators: exploiting the metabolic spectrum by controlling alternative gene programs | Q34279044 | ||
VirF-independent regulation of Shigella virB transcription is mediated by the small RNA RyhB. | Q34305594 | ||
MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system | Q34316975 | ||
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
Identification of a small-molecule inhibitor of bacterial AraC family activators | Q34567886 | ||
The future challenges facing the development of new antimicrobial drugs. | Q34988239 | ||
Exploiting genomics, genetics and chemistry to combat antibiotic resistance. | Q35140829 | ||
The challenge of multidrug resistance: actual strategies in the development of novel antibacterials | Q35152434 | ||
Physical and genetic characterization of the glnA--glnG region of the Escherichia coli chromosome | Q35383570 | ||
Shigella flexneri infection: pathogenesis and vaccine development. | Q35671854 | ||
Antimicrobial resistance among enteric pathogens | Q35797361 | ||
Fragment-based lead discovery | Q35852295 | ||
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America | Q36382134 | ||
Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. | Q36422508 | ||
Involvement of a plasmid in the invasive ability of Shigella flexneri. | Q36437346 | ||
Tsp: a tail-specific protease that selectively degrades proteins with nonpolar C termini | Q36769544 | ||
An AraC-type transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island contributes to pathogenesis and intracellular macrophage survival | Q36974415 | ||
Late stage antibacterial drugs in the clinical pipeline | Q36976704 | ||
High throughput methods of assessing protein stability and aggregation | Q37395815 | ||
Anti-virulence strategies to combat bacteria-mediated disease | Q37676924 | ||
Transcriptional control of the invasion regulatory gene virB of Shigella flexneri: activation by virF and repression by H-NS | Q38315694 | ||
LUEGO: a cost and time saving gel shift procedure | Q38331201 | ||
A multifactor regulatory circuit involving H-NS, VirF and an antisense RNA modulates transcription of the virulence gene icsA of Shigella flexneri. | Q38333799 | ||
A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains | Q38350074 | ||
Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu | Q39605636 | ||
Escape of intracellular Shigella from autophagy requires binding to cholesterol through the type III effector, IcsB. | Q39685344 | ||
Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by Shigella flexneri 2a | Q39928014 | ||
A role for H-NS in the thermo-osmotic regulation of virulence gene expression in Shigella flexneri | Q39932607 | ||
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. | Q39953337 | ||
Spontaneous insertion of an IS1-like element into the virF gene is responsible for avirulence in opaque colonial variants of Shigella flexneri 2a. | Q40148576 | ||
Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri | Q40172273 | ||
Role and regulation of the Shigella flexneri sit and MntH systems | Q40252366 | ||
Escape of intracellular Shigella from autophagy | Q40485419 | ||
Rough mutant of Shigella flexneri 2a that penetrates tissue culture cells but does not evoke keratoconjunctivitis in guinea pigs | Q40788689 | ||
The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. | Q40793797 | ||
A system for identifying post-invasion functions of invasion genes: requirements for the Mxi-Spa type III secretion pathway of Shigella flexneri in intercellular dissemination | Q40917707 | ||
Phylogenetic, structural and functional analyses of the LacI-GalR family of bacterial transcription factors | Q40936125 | ||
Shigella actin-based motility in the absence of vinculin | Q41139826 | ||
Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a. | Q41161776 | ||
Measurement of invasion by gentamicin resistance | Q41502010 | ||
IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole | Q41524587 | ||
HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells | Q41621201 | ||
New strategies for antibacterial drug design | Q41627216 | ||
Temperature-regulated expression of invasion genes inShigella flexneriis controlled through the transcriptional activation of thevirBgene on the large plasmid | Q41689426 | ||
Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor | Q41728153 | ||
IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells | Q42206130 | ||
The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri | Q42638971 | ||
Thermoregulation of Shigella and Escherichia coli EIEC pathogenicity. A temperature-dependent structural transition of DNA modulates accessibility of virF promoter to transcriptional repressor H-NS. | Q42662171 | ||
Assessment of the Alamar Blue assay for cellular growth and viability in vitro | Q42800570 | ||
Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial | Q42982958 | ||
PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. | Q43247716 | ||
OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis | Q44091047 | ||
Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 years | Q44310256 | ||
The VirF protein from Shigella flexneri is a member of the AraC transcription factor superfamily and is highly homologous to Rns, a positive regulator of virulence genes in enterotoxigenic Escherichia coli | Q45048153 | ||
PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence | Q46092317 | ||
Inoculum size in shigellosis and implications for expected mode of transmission | Q47172816 | ||
Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella | Q54040438 | ||
The DNA-binding domain as a functional indicator: the case of the AraC/XylS family of transcription factors. | Q54435894 | ||
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. | Q54450584 | ||
Role of the heat shock protein DnaJ in the lon-dependent degradation of naturally unstable proteins. | Q54576552 | ||
Leveraging the contribution of thermodynamics in drug discovery with the help of fluorescence-based thermal shift assays. | Q54600834 | ||
Expression of four virulence antigens of Shigella flexneri is positively regulated at the transcriptional level by the 30 kiloDalton virF protein. | Q54742538 | ||
pHG165: a pBR322 copy number derivative of pUC8 for cloning and expression | Q70141184 | ||
The integration and excision of the bacteriophage lambda genome | Q70974830 | ||
Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of Shigella flexneri: the expression of the virF gene | Q73486827 | ||
Differential regulation of the plasmid-encoded genes in the Shigella flexneri virulence regulon | Q73829435 | ||
The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms | Q77179814 | ||
A role for H-NS in the regulation of the virF gene of Shigella and enteroinvasive Escherichia coli | Q77390615 | ||
Neural Wiskott-Aldrich syndrome protein (N-WASP) is the specific ligand for Shigella VirG among the WASP family and determines the host cell type allowing actin-based spreading | Q77936917 | ||
An extended role for the nucleoid structuring protein H-NS in the virulence gene regulatory cascade of Shigella flexneri | Q78816863 | ||
Where will new antibiotics come from? | Q79817299 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Shigella flexneri | Q1644417 |
P304 | page(s) | 4220-4231 | |
P577 | publication date | 2013-09-03 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF. | |
P478 | volume | 81 |
Q34222413 | 3-Substituted Biquinolinium Inhibitors of AraC Family Transcriptional Activator VirF from S. flexneri Obtained Through In Situ Chemical Ionization of 3,4-Disubstituted Dihydroquinolines |
Q38760476 | Anti-virulence Strategies to Target Bacterial Infections |
Q38366322 | Approaches targeting the type III secretion system to treat or prevent bacterial infections |
Q35187657 | Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors. |
Q40076724 | Control of Virulence Gene Expression by the Master Regulator, CfaD, in the Prototypical Enterotoxigenic Escherichia coli Strain, H10407. |
Q28547782 | Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF |
Q46277703 | Molecular typing and occurrence of beta-lactam resistance genes of Shigella sonnei strains isolated during 1983-2014 in the São Paulo State in Brazil |
Q35600602 | Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth |
Q90170341 | On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome |
Q39173330 | Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs |
Q30580404 | Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri |
Q30832528 | Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators |
Q26738634 | Role of Escherichia coli in Biofuel Production |
Q39381958 | Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection |
Q28072947 | The Multifaceted Activity of the VirF Regulatory Protein in the Shigella Lifestyle |
Q42328253 | The bacterial type III secretion system as a target for developing new antibiotics |
Q41950223 | VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation |
Q38160781 | Virulence regulons of enterotoxigenic Escherichia coli. |
Q50020968 | Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options. |
Search more.